Ultragenyx Pharmaceutical Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:RARE) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -166.47 M-108.75 M-91.42 M-99.83 M-197 M -497 M Cash from investing activities 119.89 M71.06 M117.18 M-72.25 M-49 M 67 M Cash from financing activities 157 K83.65 M2 000394.19 M— — Free cash flow -166.47 M-108.75 M-91.42 M-99.83 M-197 M -497 M

News

IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study

Ultragenyx (RARE) Soars 5.2%: Is Further Upside Left in the Stock?

Ultragenyx: The Setrusumab Reset Creates A Cleaner Rare Disease Opportunity

Ultragenyx Pharmaceutical Inc. (RARE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound?

Ultragenyx Pharmaceutical Inc. (RARE) Presents at Bank of America Global Healthcare Conference 2026 Transcript

RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect

Ultragenyx (RARE) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know

Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should Know

Ultragenyx Pharmaceutical: The Market Is Overlooking 2026 Catalysts (NASDAQ:RARE)